marginally significantP = 0.05
SVO 2 %: Pooled analysis of four studies revealed that ketone supplementation led to a marginally significant increase in SVO 2 % compared to placebo (MD = 3.33, 95%CI: -0.01 to 6.68; P = 0.05; Figure 2D ).
SVO 2 %: Pooled analysis of four studies revealed that ketone supplementation led to a marginally significant increase in SVO 2 % compared to placebo (MD = 3.33, 95%CI: -0.01 to 6.68; P = 0.05; Figure 2D ).
In subgroup analysis, patients with HFrEF showed a trend toward improved S’max, although this did not reach statistical significance (MD = 3.03; 95%CI: -0.30 to 6.36; P = 0.07).